About Maria Belvisi

My own area is Respiratory & Immunology within Research & Development, BioPharmaceuticals R&D at AstraZeneca. AstraZeneca’s vision is to apply our research and development capabilities and technologies to accelerate the progress of our pipeline.

Each year we invest in excess of $1 billion in discovering and developing the next generation of life-changing medicines, from initial target selection through to the end of Phase II trials. We employ over 2,300 scientists and undertake research on a truly global scale, operating vibrant science centres across three continents.

Partnering and collaboration is a way of life for our teams. We work alongside scientists at many of the world’s leading academic institutions to help accelerate the translation of science into drug discovery and ultimately innovative medicines. We are pioneering new approaches to Open Innovation, creating a more permeable research environment where our scientists can freely share their ideas and collaborate.

I joined AstraZeneca to prosecute targets, develop therapeutic solutions and thereby impact patient health in patients with respiratory disease.